
Kimberly-Clark Corporation (KMB)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
101.47 - Open
102.19 - Bid 96.04 x 100
- Ask 108.20 x 100
- Day's Range
101.64 - 103.21 - 52 Week Range
92.42 - 137.46 - Volume
8,453,262 - Avg. Volume
4,784,925 - Market Cap (intraday)
34.044B - Beta (5Y Monthly) 0.30
- PE Ratio (TTM)
19.84 - EPS (TTM)
5.17 - Earnings Date Aug 10, 2026
- Forward Dividend & Yield 5.12 (4.91%)
- Ex-Dividend Date Jun 5, 2026
- 1y Target Est
114.67
Recent News
View MorePerformance Overview
Trailing total returns as of 6/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
34.04B
-
Enterprise Value
40.59B
-
Trailing P/E
19.84
-
Forward P/E
13.68
-
PEG Ratio (5yr expected)
2.07
-
Price/Sales (ttm)
2.06
-
Price/Book (mrq)
18.96
-
Enterprise Value/Revenue
2.45
-
Enterprise Value/EBITDA
12.64
Financial Highlights
Profitability and Income Statement
-
Profit Margin
12.80%
-
Return on Assets (ttm)
10.16%
-
Return on Equity (ttm)
111.73%
-
Revenue (ttm)
16.56B
-
Net Income Avi to Common (ttm)
1.72B
-
Diluted EPS (ttm)
5.17
Balance Sheet and Cash Flow
-
Total Cash (mrq)
542M
-
Total Debt/Equity (mrq)
371.26%
-
Levered Free Cash Flow (ttm)
1.05B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports
View More-
Recent weakness presents buying opportunity
KMB manufactures a variety of consumer products, primarily derived from synthetic and natural fibers. It is organized into two business segments: North America and International Personal Care. Its leading brands include Huggies, Kleenex, Kotex, Depend, and Scott. The company is based in Dallas and has approximately 36,000 employees.
RatingPrice Target -
The major indices are mixed at midday on Wednesday. Inflation on the wholesale
The major indices are mixed at midday on Wednesday. Inflation on the wholesale side is rising faster than expected. Headline PPI came in at 6.0% for April, well above the 4.3% pace the month prior. Core PPI was 4.4% for April, also well above the 3.7% rate the month prior. Today's data follows a bump in CPI yesterday. Gas prices at the pump have been rising as well. Crude oil is back up to $104 per barrel. The yield on the 10-year note is 4.49%, and the VIX volatility index is at 18.
-
Kimberly-Clark Earnings: Winning Innovation Buoys Volumes; Kenvue Deal Nears Close; Shares a Bargain
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
RatingPrice Target -
Even Amid Portfolio Changes, Narrow-Moat Kimberly-Clark Wedded to Prudent Brand Investments
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
RatingPrice Target










